RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Icure Pharmaceutical Stock

Icure Pharmaceutical ROE 2025

Icure Pharmaceutical ROE

0.02

Ticker

175250.KQ

ISIN

KR7175250000

In 2025, Icure Pharmaceutical's return on equity (ROE) was 0.02, a -103.23% increase from the -0.54 ROE in the previous year.

Icure Pharmaceutical Aktienanalyse

What does Icure Pharmaceutical do?

Icure Pharmaceutical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Icure Pharmaceutical's Return on Equity (ROE)

Icure Pharmaceutical's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Icure Pharmaceutical's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Icure Pharmaceutical's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Icure Pharmaceutical’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Icure Pharmaceutical stock

What is the ROE (Return on Equity) of Icure Pharmaceutical this year?

The ROE of Icure Pharmaceutical this year is 0.02 undefined.

How has the Return on Equity (ROE) of Icure Pharmaceutical developed compared to the previous year?

The ROE of Icure Pharmaceutical has increased by -103.23% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Icure Pharmaceutical?

A high ROE indicates that Icure Pharmaceutical generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Icure Pharmaceutical?

A low ROE can indicate that Icure Pharmaceutical is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Icure Pharmaceutical affect the company?

A change in ROE (Return on Equity) of Icure Pharmaceutical can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Icure Pharmaceutical?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Icure Pharmaceutical?

Some factors that can influence Icure Pharmaceutical's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Icure Pharmaceutical pay?

Over the past 12 months, Icure Pharmaceutical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Icure Pharmaceutical is expected to pay a dividend of 0 KRW.

What is the dividend yield of Icure Pharmaceutical?

The current dividend yield of Icure Pharmaceutical is .

When does Icure Pharmaceutical pay dividends?

Icure Pharmaceutical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Icure Pharmaceutical?

Icure Pharmaceutical paid dividends every year for the past 0 years.

What is the dividend of Icure Pharmaceutical?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Icure Pharmaceutical located?

Icure Pharmaceutical is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Icure Pharmaceutical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Icure Pharmaceutical from 7/30/2025 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 7/30/2025.

When did Icure Pharmaceutical pay the last dividend?

The last dividend was paid out on 7/30/2025.

What was the dividend of Icure Pharmaceutical in the year 2024?

In the year 2024, Icure Pharmaceutical distributed 0 KRW as dividends.

In which currency does Icure Pharmaceutical pay out the dividend?

The dividends of Icure Pharmaceutical are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Icure Pharmaceutical

Our stock analysis for Icure Pharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Icure Pharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.